LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE

LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE was reported 54097 times

LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 LOCAL ANAESTHETIC SYSTEMIC TOXICITY 629 0.5923
1 INSPIRATORY CAPACITY DECREASED 88 0.3177
2 SLEEP DISORDER THERAPY 61 0.3081
3 APPENDICOLITH 89 0.2300
4 ANALGESIC THERAPY 61 0.1900
5 DRUG THERAPY 61 0.1799
6 MATERNAL EXPOSURE DURING DELIVERY 157 0.1584
7 TOXIC ANTERIOR SEGMENT SYNDROME 170 0.1558
8 INFUSION SITE DISCHARGE 220 0.1254
9 METHAEMOGLOBINAEMIA 248 0.1070
10 LAGOPHTHALMOS 43 0.1051
11 INFUSION SITE MASS 97 0.0892
12 INFUSION SITE URTICARIA 59 0.0881
13 INFUSION SITE BRUISING 179 0.0828
14 INFUSION SITE PRURITUS 255 0.0807
15 INFUSION SITE HAEMORRHAGE 240 0.0729
16 CAUDA EQUINA SYNDROME 50 0.0651
17 PROCEDURAL HYPOTENSION 52 0.0611
18 INFUSION SITE RASH 83 0.0605
19 INFUSION SITE SWELLING 374 0.0594
20 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 62 0.0584
21 ANAESTHETIC COMPLICATION NEUROLOGICAL 51 0.0563
22 INFUSION SITE DISCOMFORT 58 0.0559
23 ANAESTHETIC COMPLICATION 145 0.0539
24 INFUSION SITE NODULE 50 0.0520
25 INFUSION SITE WARMTH 59 0.0481
26 KOUNIS SYNDROME 109 0.0480
27 NEPHROGENIC ANAEMIA 209 0.0451
28 INFUSION SITE IRRITATION 57 0.0444
29 HYPERPARATHYROIDISM SECONDARY 111 0.0443
30 HYPERPHOSPHATAEMIA 94 0.0437
31 DEVICE INFUSION ISSUE 108 0.0435
32 INFUSION SITE ERYTHEMA 364 0.0431
33 INFUSION SITE PAIN 546 0.0423
34 INCORRECT DRUG ADMINISTRATION RATE 178 0.0418
35 INFUSION SITE EXTRAVASATION 248 0.0398
36 HYPERTHERMIA MALIGNANT 57 0.0383
37 MULTIPLE ALLERGIES 295 0.0376
38 ADMINISTRATION SITE PAIN 43 0.0373
39 VASOPLEGIA SYNDROME 61 0.0372
40 RETINAL VASCULITIS 44 0.0369
41 BLOOD PHOSPHORUS INCREASED 92 0.0337
42 INSURANCE ISSUE 508 0.0332
43 INFUSION SITE REACTION 90 0.0301
44 SEASONAL ALLERGY 419 0.0296
45 PULSELESS ELECTRICAL ACTIVITY 121 0.0289
46 CORNEAL OEDEMA 62 0.0276
47 INFUSION SITE INDURATION 40 0.0270
48 TOTAL LUNG CAPACITY DECREASED 42 0.0263
49 VENTRICULAR FIBRILLATION 278 0.0250
50 REBOUND ACID HYPERSECRETION 75 0.0248
51 DERMATITIS CONTACT 272 0.0238
52 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 78 0.0235
53 OBSTRUCTION 91 0.0228
54 RESPIRATORY TRACT INFECTION VIRAL 53 0.0227
55 STRESS CARDIOMYOPATHY 130 0.0223
56 VENTRICULAR TACHYCARDIA 351 0.0212
57 IRON DEFICIENCY 94 0.0209
58 LUNG OPACITY 55 0.0208
59 PARAPLEGIA 60 0.0208
60 END STAGE RENAL DISEASE 375 0.0205
61 PULSE ABSENT 96 0.0202
62 ANAPHYLACTIC SHOCK 517 0.0200
63 POOR VENOUS ACCESS 204 0.0197
64 EAR INFECTION 518 0.0194
65 RESPIRATORY TRACT INFECTION 504 0.0193
66 SINUSITIS 1951 0.0190
67 CHRONIC SINUSITIS 71 0.0189
68 INGROWING NAIL 43 0.0182
69 TYPE I HYPERSENSITIVITY 62 0.0176
70 AORTIC STENOSIS 61 0.0175
71 GENERALISED TONIC-CLONIC SEIZURE 289 0.0174
72 VENTRICULAR HYPOKINESIA 56 0.0174
73 STATUS EPILEPTICUS 196 0.0173
74 PRODUCT DISTRIBUTION ISSUE 159 0.0171
75 CARDIOGENIC SHOCK 245 0.0171
76 HYPOPHOSPHATAEMIA 125 0.0169
77 ANIMAL BITE 45 0.0169
78 OTITIS MEDIA 55 0.0166
79 UPPER RESPIRATORY TRACT INFECTION 769 0.0166
80 MYASTHENIA GRAVIS 130 0.0161
81 VASCULAR DEVICE INFECTION 73 0.0161
82 LUMBAR SPINAL STENOSIS 47 0.0161
83 APNOEA 125 0.0160
84 HAEMODYNAMIC INSTABILITY 122 0.0160
85 RHINOVIRUS INFECTION 62 0.0159
86 SKIN ABRASION 75 0.0159
87 RETINAL ARTERY OCCLUSION 40 0.0158
88 CATHETER SITE PAIN 41 0.0158
89 PRODUCT ADHESION ISSUE 559 0.0156
90 BLOOD URIC ACID INCREASED 89 0.0154
91 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 79 0.0154
92 STREPTOCOCCAL INFECTION 85 0.0153
93 BUNDLE BRANCH BLOCK LEFT 64 0.0151
94 VENTRICULAR ARRHYTHMIA 55 0.0150
95 HYPERCAPNIA 45 0.0149
96 ANHEDONIA 392 0.0149
97 DEAFNESS NEUROSENSORY 49 0.0149
98 LARYNGOSPASM 40 0.0149
99 SKIN INFECTION 165 0.0147
100 ANAPHYLACTIC REACTION 802 0.0145
101 RENAL INJURY 427 0.0144
102 SINUS TACHYCARDIA 204 0.0144
103 STRIDOR 41 0.0139
104 GASTROENTERITIS VIRAL 249 0.0138
105 MULTI-ORGAN FAILURE 236 0.0136
106 ARTHRITIS BACTERIAL 56 0.0136
107 TENDERNESS 141 0.0135
108 APPENDICITIS 126 0.0135
109 ATELECTASIS 130 0.0134
110 PHARYNGITIS STREPTOCOCCAL 145 0.0134
111 PROCTALGIA 86 0.0134
112 MENINGITIS ASEPTIC 60 0.0134
113 BRONCHIECTASIS 90 0.0133
114 FEAR 355 0.0132
115 SPINAL CORD COMPRESSION 51 0.0131
116 BRAIN HERNIATION 39 0.0130
117 PARADOXICAL DRUG REACTION 48 0.0130
118 SPINAL OSTEOARTHRITIS 113 0.0128
119 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 65 0.0128
120 VENTRICULAR EXTRASYSTOLES 132 0.0127
121 SKIN LACERATION 137 0.0126
122 RESPIRATORY DEPRESSION 153 0.0125
123 RESPIRATORY ACIDOSIS 49 0.0125
124 INTERVERTEBRAL DISC DEGENERATION 114 0.0123
125 TOOTH INFECTION 162 0.0123
126 ENDOPHTHALMITIS 73 0.0122
127 LIVE BIRTH 101 0.0121
128 GASTROINTESTINAL INFECTION 108 0.0120
129 HYPOXIA 423 0.0120
130 BACTERIAL INFECTION 224 0.0120
131 LYME DISEASE 40 0.0120
132 CARDIAC ARREST 987 0.0119
133 UNRESPONSIVE TO STIMULI 308 0.0119
134 NYSTAGMUS 63 0.0119
135 PRODUCT ADMINISTRATION INTERRUPTED 93 0.0118
136 SINUS BRADYCARDIA 113 0.0117
137 BRONCHITIS 855 0.0115
138 HORDEOLUM 49 0.0113
139 BRADYCARDIA 598 0.0113
140 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 193 0.0112
141 HYPERLIPIDAEMIA 134 0.0112
142 ARTHRITIS INFECTIVE 52 0.0112
143 TROPONIN INCREASED 85 0.0112
144 DECUBITUS ULCER 91 0.0112
145 BREATH SOUNDS ABNORMAL 55 0.0111
146 NEUROTOXICITY 195 0.0111
147 KIDNEY INFECTION 218 0.0111
148 NEURALGIA 270 0.0111
149 RESPIRATORY SYNCYTIAL VIRUS INFECTION 96 0.0110
150 SINUS DISORDER 218 0.0110
151 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 97 0.0110
152 BRAIN OEDEMA 138 0.0109
153 PNEUMONIA FUNGAL 43 0.0109
154 CHRONIC KIDNEY DISEASE 828 0.0109
155 VIRAL INFECTION 360 0.0108
156 PSEUDOMONAS INFECTION 92 0.0107
157 TORSADE DE POINTES 84 0.0107
158 SENSORY LOSS 86 0.0107
159 MYDRIASIS 136 0.0106
160 EYE INFECTION 119 0.0105
161 PERIPHERAL VASCULAR DISORDER 54 0.0105
162 POST PROCEDURAL INFECTION 85 0.0104
163 MENTAL STATUS CHANGES 290 0.0104
164 WEIGHT FLUCTUATION 108 0.0103
165 HYPERVOLAEMIA 51 0.0103
166 GLUCOSE TOLERANCE IMPAIRED 61 0.0103
167 NORMAL NEWBORN 56 0.0103
168 TRIGEMINAL NEURALGIA 41 0.0102
169 BRONCHOSPASM 145 0.0102
170 CANDIDA INFECTION 171 0.0101
171 TOOTH ABSCESS 103 0.0101
172 PRE-EXISTING CONDITION IMPROVED 63 0.0101
173 FOOD POISONING 54 0.0101
174 PHARYNGITIS 125 0.0101
175 POST PROCEDURAL COMPLICATION 193 0.0100
176 IMMUNE THROMBOCYTOPENIA 46 0.0100
177 HEPARIN-INDUCED THROMBOCYTOPENIA 49 0.0099
178 CIRCULATORY COLLAPSE 169 0.0099
179 INFUSION RELATED REACTION 657 0.0099
180 RHINITIS ALLERGIC 44 0.0099
181 STAPHYLOCOCCAL INFECTION 326 0.0099
182 RALES 57 0.0098
183 MYOCLONUS 117 0.0098
184 LEFT VENTRICULAR DYSFUNCTION 65 0.0097
185 HYPOAESTHESIA ORAL 146 0.0097
186 CONCUSSION 74 0.0095
187 CYSTITIS 304 0.0095
188 CARDIOTOXICITY 85 0.0095
189 LOCALISED INFECTION 230 0.0095
190 VARICOSE VEIN 49 0.0095
191 SKIN NECROSIS 49 0.0094
192 MENINGITIS 63 0.0094
193 PROCEDURAL COMPLICATION 72 0.0094
194 DIVERTICULUM INTESTINAL 41 0.0094
195 ARTHROPOD BITE 68 0.0092
196 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 502 0.0091
197 ESCHERICHIA INFECTION 75 0.0091
198 FOOD ALLERGY 70 0.0091
199 RIB FRACTURE 185 0.0090
200 RENAL FAILURE 1185 0.0089
201 STAPHYLOCOCCAL SEPSIS 44 0.0089
202 SPINAL COLUMN STENOSIS 42 0.0089
203 URINARY TRACT INFECTION 1509 0.0088
204 ECONOMIC PROBLEM 134 0.0088
205 NERVE INJURY 98 0.0088
206 INJURY 618 0.0088
207 RENAL TUBULAR NECROSIS 86 0.0088
208 ACUTE RESPIRATORY FAILURE 168 0.0087
209 HYPERAESTHESIA 71 0.0086
210 CELLULITIS 432 0.0086
211 SUPRAVENTRICULAR TACHYCARDIA 82 0.0086
212 ATRIOVENTRICULAR BLOCK COMPLETE 57 0.0085
213 ROTATOR CUFF SYNDROME 108 0.0084
214 HAEMORRHOIDS 164 0.0084
215 SCIATICA 134 0.0084
216 FACIAL PAIN 75 0.0084
217 LIGAMENT SPRAIN 83 0.0084
218 COVID-19 PNEUMONIA 99 0.0084
219 ACUTE PULMONARY OEDEMA 47 0.0084
220 MIOSIS 67 0.0083
221 GINGIVITIS 45 0.0083
222 NERVE COMPRESSION 77 0.0083
223 IMPAIRED GASTRIC EMPTYING 113 0.0083
224 PRODUCTIVE COUGH 394 0.0082
225 LYMPHOEDEMA 57 0.0082
226 LIMB INJURY 222 0.0082
227 MUSCULOSKELETAL CHEST PAIN 126 0.0081
228 BEHAVIOUR DISORDER 44 0.0081
229 BENIGN PROSTATIC HYPERPLASIA 42 0.0081
230 GRAND MAL CONVULSION 75 0.0081
231 HYPOTENSION 1626 0.0081
232 FIBROMYALGIA 197 0.0081
233 FACIAL PARALYSIS 69 0.0081
234 MUSCLE STRAIN 70 0.0081
235 TACHYPNOEA 110 0.0081
236 ILLNESS 833 0.0081
237 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 44 0.0081
238 SCAR 138 0.0081
239 ORAL CANDIDIASIS 106 0.0080
240 IRON DEFICIENCY ANAEMIA 74 0.0080
241 POSTOPERATIVE WOUND INFECTION 54 0.0080
242 COVID-19 1400 0.0080
243 DRUG LEVEL INCREASED 132 0.0080
244 RESPIRATORY TRACT CONGESTION 126 0.0079
245 UPPER-AIRWAY COUGH SYNDROME 65 0.0079
246 ECCHYMOSIS 54 0.0079
247 SPINAL PAIN 92 0.0078
248 VITREOUS FLOATERS 77 0.0078
249 THERAPY PARTIAL RESPONDER 122 0.0078
250 RENAL CYST 62 0.0078
251 HIATUS HERNIA 101 0.0078
252 HYPERKERATOSIS 43 0.0078
253 FOOT FRACTURE 147 0.0077
254 FAILURE TO THRIVE 40 0.0077
255 MULTIPLE ORGAN DYSFUNCTION SYNDROME 218 0.0077
256 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 401 0.0077
257 OSTEOMYELITIS 139 0.0077
258 EXOSTOSIS 70 0.0077
259 TACHYCARDIA 680 0.0076
260 CLOSTRIDIUM DIFFICILE COLITIS 81 0.0076
261 SKIN WARM 44 0.0076
262 ANAL INCONTINENCE 68 0.0076
263 FEBRILE NEUTROPENIA 500 0.0075
264 SLEEP APNOEA SYNDROME 143 0.0075
265 HAND FRACTURE 53 0.0075
266 TOXICITY TO VARIOUS AGENTS 1261 0.0075
267 COMPRESSION FRACTURE 40 0.0075
268 INJECTION SITE DISCHARGE 40 0.0074
269 JOINT EFFUSION 51 0.0074
270 OSTEOPENIA 112 0.0074
271 SENSITIVE SKIN 54 0.0073
272 CYANOSIS 115 0.0073
273 AUTOIMMUNE DISORDER 71 0.0073
274 SINUS CONGESTION 98 0.0072
275 ULCER 115 0.0072
276 CARPAL TUNNEL SYNDROME 101 0.0072
277 OBSTRUCTIVE AIRWAYS DISORDER 80 0.0072
278 PNEUMOTHORAX 114 0.0072
279 VITAMIN D DEFICIENCY 70 0.0072
280 RETINAL HAEMORRHAGE 51 0.0072
281 CARDIOMEGALY 88 0.0071
282 OXYGEN SATURATION DECREASED 402 0.0071
283 PARAESTHESIA ORAL 103 0.0071
284 UNEVALUABLE EVENT 538 0.0071
285 RESPIRATORY DISTRESS 196 0.0071
286 EYELID PTOSIS 72 0.0071
287 DIPLOPIA 184 0.0071
288 BLOOD CALCIUM INCREASED 62 0.0071
289 INADEQUATE ANALGESIA 60 0.0071
290 SPINAL COMPRESSION FRACTURE 58 0.0070
291 POST-TRAUMATIC STRESS DISORDER 47 0.0070
292 BODY TEMPERATURE INCREASED 143 0.0070
293 INCONTINENCE 74 0.0070
294 HEREDITARY ANGIOEDEMA 75 0.0070
295 GOUT 125 0.0070
296 FLANK PAIN 65 0.0069
297 MASS 96 0.0069
298 ASPIRATION 75 0.0068
299 BURSITIS 83 0.0068
300 DYSARTHRIA 257 0.0068
301 SMALL INTESTINAL OBSTRUCTION 84 0.0068
302 NECK PAIN 381 0.0068
303 INTERVERTEBRAL DISC PROTRUSION 149 0.0068
304 ENCEPHALOPATHY 167 0.0068
305 PREMATURE DELIVERY 108 0.0068
306 PNEUMONIA BACTERIAL 62 0.0067
307 SEROTONIN SYNDROME 129 0.0067
308 MALNUTRITION 75 0.0067
309 BRAIN FOG 105 0.0067
310 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 52 0.0067
311 ORAL DISORDER 49 0.0067
312 IMPAIRED QUALITY OF LIFE 96 0.0067
313 WOUND INFECTION 73 0.0067
314 FUNGAL INFECTION 222 0.0067
315 WRONG PRODUCT ADMINISTERED 45 0.0067
316 SPINAL DISORDER 63 0.0066
317 SEPSIS 740 0.0066
318 HYPERCHOLESTEROLAEMIA 64 0.0066
319 JOINT DISLOCATION 70 0.0066
320 PULMONARY MASS 98 0.0066
321 DRUG TOXICITY 89 0.0065
322 THERAPY NON-RESPONDER 292 0.0065
323 LARYNGEAL OEDEMA 40 0.0065
324 BACTERAEMIA 77 0.0065
325 DIVERTICULUM 46 0.0065
326 PULMONARY OEDEMA 289 0.0064
327 BODY HEIGHT DECREASED 69 0.0064
328 MUSCULOSKELETAL DISCOMFORT 111 0.0064
329 HYPOALBUMINAEMIA 50 0.0064
330 NEPHROPATHY 60 0.0064
331 TRICUSPID VALVE INCOMPETENCE 51 0.0064
332 PNEUMONIA ASPIRATION 160 0.0064
333 PULMONARY CONGESTION 84 0.0064
334 HERPES ZOSTER 366 0.0064
335 CLOSTRIDIUM DIFFICILE INFECTION 139 0.0064
336 INFLUENZA 710 0.0064
337 PNEUMONIA 2054 0.0063
338 BLOOD PRESSURE ABNORMAL 126 0.0063
339 PHARYNGEAL SWELLING 62 0.0063
340 SPUTUM DISCOLOURED 60 0.0063
341 OEDEMA 343 0.0063
342 DIVERTICULITIS 175 0.0063
343 MIGRAINE 602 0.0063
344 MOTOR DYSFUNCTION 64 0.0063
345 POOR QUALITY SLEEP 135 0.0063
346 PLEURAL EFFUSION 380 0.0062
347 RESPIRATION ABNORMAL 43 0.0062
348 LUNG INFILTRATION 55 0.0062
349 JOINT INJURY 133 0.0062
350 CARDIO-RESPIRATORY ARREST 260 0.0062
351 RESPIRATORY FAILURE 453 0.0062
352 RHINITIS 50 0.0062
353 ACCIDENT 74 0.0062
354 DELIRIUM 215 0.0062
355 BRAIN INJURY 62 0.0062
356 CYTOKINE RELEASE SYNDROME 124 0.0062
357 UROSEPSIS 57 0.0062
358 SHOCK 142 0.0062
359 EAR PAIN 120 0.0062
360 CONTUSION 594 0.0062
361 ORAL PAIN 138 0.0062
362 HAEMATOCRIT DECREASED 122 0.0061
363 BLOOD PRESSURE DECREASED 407 0.0061
364 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1098 0.0061
365 SPINAL OPERATION 75 0.0061
366 PARALYSIS 87 0.0061
367 WALKING AID USER 40 0.0061
368 RESPIRATORY ARREST 167 0.0061
369 EYE MOVEMENT DISORDER 41 0.0060
370 ASCITES 176 0.0060
371 BACK INJURY 65 0.0060
372 PAPULE 42 0.0060
373 ACUTE KIDNEY INJURY 911 0.0059
374 EMPHYSEMA 60 0.0059
375 APHTHOUS ULCER 46 0.0059
376 NEPHROLITHIASIS 272 0.0059
377 BLOOD ALBUMIN DECREASED 47 0.0059
378 MITRAL VALVE INCOMPETENCE 67 0.0059
379 PRODUCT DOSE OMISSION ISSUE 1738 0.0059
380 PELVIC FRACTURE 46 0.0059
381 ATAXIA 70 0.0059
382 ELECTROCARDIOGRAM QT PROLONGED 212 0.0059
383 PROCEDURAL PAIN 163 0.0059
384 EXTRASYSTOLES 41 0.0059
385 MICTURITION URGENCY 67 0.0059
386 NASOPHARYNGITIS 1079 0.0058
387 RIGHT VENTRICULAR FAILURE 41 0.0058
388 BACK PAIN 1359 0.0058
389 METABOLIC ACIDOSIS 187 0.0058
390 BACK DISORDER 95 0.0058
391 INABILITY TO AFFORD MEDICATION 58 0.0058
392 ANKLE FRACTURE 90 0.0058
393 SKIN ULCER 150 0.0058
394 LEUKOCYTOSIS 105 0.0058
395 LOW BIRTH WEIGHT BABY 46 0.0058
396 HOSPICE CARE 57 0.0058
397 CONJUNCTIVITIS 107 0.0058
398 SEIZURE 665 0.0058
399 OSTEOARTHRITIS 244 0.0057
400 NODULE 75 0.0057
401 DYSPNOEA EXERTIONAL 216 0.0057
402 APHONIA 80 0.0057
403 PULMONARY HYPERTENSION 119 0.0057
404 INFECTION 822 0.0057
405 JOINT RANGE OF MOTION DECREASED 76 0.0057
406 OSTEOPOROSIS 233 0.0057
407 PREMATURE BABY 170 0.0056
408 SPINAL FRACTURE 113 0.0056
409 BLADDER DISORDER 56 0.0056
410 DEPRESSED LEVEL OF CONSCIOUSNESS 222 0.0056
411 MAJOR DEPRESSION 41 0.0056
412 DEVICE RELATED INFECTION 86 0.0056
413 GROIN PAIN 49 0.0056
414 CHILLS 653 0.0056
415 DISABILITY 110 0.0056
416 BLINDNESS TRANSIENT 41 0.0056
417 BLOOD PRESSURE DIASTOLIC DECREASED 41 0.0055
418 PAIN IN JAW 157 0.0055
419 DENTAL CARIES 61 0.0055
420 SWELLING 515 0.0055
421 HYPERTHERMIA 42 0.0055
422 ORAL HERPES 107 0.0055
423 HYDRONEPHROSIS 41 0.0055
424 TOOTHACHE 99 0.0055
425 RENAL FAILURE CHRONIC 42 0.0055
426 ATRIOVENTRICULAR BLOCK 42 0.0054
427 ARTERIOSCLEROSIS 51 0.0054
428 RESPIRATORY DISORDER 162 0.0054
429 HEAD INJURY 171 0.0054
430 ATRIAL FIBRILLATION 525 0.0054
431 ATRIAL FLUTTER 43 0.0054
432 TUBULOINTERSTITIAL NEPHRITIS 101 0.0054
433 LOWER RESPIRATORY TRACT INFECTION 245 0.0054
434 MUSCLE RIGIDITY 64 0.0053
435 TOOTH DISORDER 119 0.0053
436 EJECTION FRACTION DECREASED 83 0.0053
437 BLOOD MAGNESIUM DECREASED 46 0.0053
438 ABSCESS 85 0.0053
439 RENAL FAILURE ACUTE 226 0.0053
440 ACUTE CORONARY SYNDROME 44 0.0053
441 PURPURA 47 0.0053
442 APPLICATION SITE PAIN 117 0.0053
443 BLOOD IRON DECREASED 63 0.0053
444 SUBSTANCE ABUSE 43 0.0053
445 HEART RATE DECREASED 185 0.0053
446 HYPOKALAEMIA 243 0.0053
447 DIZZINESS POSTURAL 51 0.0053
448 WRIST FRACTURE 63 0.0053
449 GASTROOESOPHAGEAL REFLUX DISEASE 422 0.0052
450 PAIN 3215 0.0052
451 FALL 1739 0.0052
452 BLOOD POTASSIUM DECREASED 157 0.0052
453 OROPHARYNGEAL PAIN 483 0.0052
454 BLOOD UREA INCREASED 87 0.0052
455 HEMIPARESIS 88 0.0052
456 HEPATOMEGALY 51 0.0052
457 MYOCARDIAL ISCHAEMIA 59 0.0052
458 LOSS OF CONSCIOUSNESS 664 0.0052
459 ELECTROLYTE IMBALANCE 60 0.0052
460 ANXIETY 1465 0.0051
461 PULMONARY THROMBOSIS 56 0.0051
462 HYPERTENSIVE CRISIS 57 0.0051
463 MUSCLE TIGHTNESS 83 0.0051
464 MUSCLE TWITCHING 118 0.0051
465 RETINAL DETACHMENT 47 0.0051
466 HYPOMAGNESAEMIA 71 0.0051
467 IRRITABLE BOWEL SYNDROME 109 0.0051
468 NEUTROPHIL COUNT INCREASED 52 0.0051
469 PYELONEPHRITIS 44 0.0051
470 LETHARGY 292 0.0051
471 UPPER LIMB FRACTURE 101 0.0051
472 ILEUS 63 0.0051
473 POST PROCEDURAL HAEMORRHAGE 59 0.0051
474 HYPONATRAEMIA 284 0.0050
475 MYOSITIS 45 0.0050
476 STOMATITIS 304 0.0050
477 CARDIOMYOPATHY 74 0.0050
478 OROPHARYNGEAL DISCOMFORT 45 0.0050
479 BLOOD CALCIUM DECREASED 56 0.0050
480 HAEMATOMA 129 0.0050
481 INTENTIONAL PRODUCT USE ISSUE 435 0.0050
482 FOOT DEFORMITY 55 0.0050
483 URINARY INCONTINENCE 147 0.0050
484 CATARACT 295 0.0049
485 DRUG INTERACTION 785 0.0049
486 BONE DISORDER 90 0.0049
487 GENERALISED OEDEMA 61 0.0049
488 PALLOR 133 0.0049
489 LYMPHADENOPATHY 173 0.0049
490 EMOTIONAL DISTRESS 591 0.0049
491 NEUROPATHY PERIPHERAL 463 0.0049
492 PSYCHOLOGICAL TRAUMA 42 0.0049
493 HAEMOPTYSIS 135 0.0048
494 ACCIDENTAL OVERDOSE 177 0.0048
495 CYST 60 0.0048
496 BLOOD PRESSURE INCREASED 738 0.0048
497 URINARY RETENTION 161 0.0048
498 EYE INFLAMMATION 46 0.0048
499 LIMB DISCOMFORT 149 0.0048
500 SUBARACHNOID HAEMORRHAGE 49 0.0048
501 COMA 229 0.0048
502 PYREXIA 1659 0.0048
503 HYPERTENSION 1015 0.0048
504 BLOOD TEST ABNORMAL 67 0.0048
505 COUGH 1337 0.0048
506 TINNITUS 219 0.0048
507 HYPERKALAEMIA 167 0.0048
508 OESOPHAGITIS 52 0.0048
509 LYMPHOCYTE COUNT DECREASED 84 0.0047
510 NASAL CONGESTION 279 0.0047
511 PHOTOPHOBIA 89 0.0047
512 RESTLESS LEGS SYNDROME 86 0.0047
513 DISCOMFORT 288 0.0047
514 TOOTH FRACTURE 52 0.0047
515 COLD SWEAT 83 0.0047
516 DISSEMINATED INTRAVASCULAR COAGULATION 66 0.0047
517 ROAD TRAFFIC ACCIDENT 196 0.0047
518 BASAL CELL CARCINOMA 73 0.0047
519 INCREASED TENDENCY TO BRUISE 43 0.0047
520 MUCOSAL INFLAMMATION 122 0.0047
521 SCRATCH 49 0.0046
522 OCULAR DISCOMFORT 52 0.0046
523 CARDIAC MURMUR 40 0.0046
524 QUALITY OF LIFE DECREASED 62 0.0046
525 BLOOD SODIUM DECREASED 87 0.0046
526 HYPOTONIA 46 0.0046
527 PRESYNCOPE 112 0.0046
528 WHEEZING 273 0.0046
529 EXPOSURE DURING PREGNANCY 286 0.0046
530 LIVER FUNCTION TEST INCREASED 98 0.0046
531 COAGULOPATHY 76 0.0046
532 HEADACHE 2856 0.0046
533 RENAL IMPAIRMENT 382 0.0045
534 RESTLESSNESS 166 0.0045
535 BLOOD URINE PRESENT 86 0.0045
536 RENAL PAIN 48 0.0045
537 SEPTIC SHOCK 197 0.0045
538 PRODUCT USE IN UNAPPROVED INDICATION 1120 0.0045
539 DEHYDRATION 602 0.0045
540 HERNIA 87 0.0045
541 CONSTIPATION 980 0.0045
542 TOXIC EPIDERMAL NECROLYSIS 68 0.0045
543 LOWER LIMB FRACTURE 86 0.0045
544 CHROMATURIA 101 0.0045
545 HALLUCINATION, VISUAL 94 0.0044
546 DERMATITIS ALLERGIC 56 0.0044
547 FULL BLOOD COUNT ABNORMAL 47 0.0044
548 HEART RATE INCREASED 440 0.0044
549 NEOPLASM 51 0.0044
550 WOUND 124 0.0044
551 GASTROINTESTINAL DISORDER 396 0.0044
552 ABDOMINAL DISTENSION 461 0.0044
553 HYPOTHYROIDISM 141 0.0044
554 ANGIOEDEMA 195 0.0044
555 COMPLICATION ASSOCIATED WITH DEVICE 64 0.0044
556 THROMBOSIS 354 0.0044
557 ERYTHEMA MULTIFORME 41 0.0044
558 HYPOAESTHESIA 657 0.0044
559 DEFORMITY 41 0.0044
560 MATERNAL EXPOSURE DURING PREGNANCY 390 0.0044
561 DYSURIA 161 0.0044
562 PERIPHERAL SWELLING 670 0.0043
563 FLUID RETENTION 221 0.0043
564 APHASIA 131 0.0043
565 RED BLOOD CELL COUNT DECREASED 124 0.0043
566 BURNING SENSATION 302 0.0043
567 INTRAOCULAR PRESSURE INCREASED 55 0.0043
568 TRANSFUSION 45 0.0043
569 CONFUSIONAL STATE 694 0.0043
570 BLOOD CHOLESTEROL INCREASED 200 0.0043
571 VISUAL ACUITY REDUCED 142 0.0043
572 EYE PAIN 241 0.0043
573 MOUTH ULCERATION 90 0.0043
574 CHEST PAIN 790 0.0043
575 SKIN DISCOLOURATION 196 0.0043
576 NERVOUS SYSTEM DISORDER 133 0.0043
577 SQUAMOUS CELL CARCINOMA 40 0.0042
578 ACUTE RESPIRATORY DISTRESS SYNDROME 75 0.0042
579 CHEST DISCOMFORT 434 0.0042
580 EPISTAXIS 317 0.0042
581 SOMNOLENCE 852 0.0042
582 ASTHMA 478 0.0042
583 SWOLLEN TONGUE 132 0.0042
584 NEEDLE ISSUE 123 0.0042
585 ARTHRITIS 331 0.0042
586 GLAUCOMA 81 0.0042
587 HEART RATE IRREGULAR 95 0.0042
588 INFLUENZA LIKE ILLNESS 346 0.0042
589 ANAEMIA 801 0.0042
590 TENDONITIS 65 0.0042
591 WHITE BLOOD CELL COUNT INCREASED 161 0.0042
592 SLEEP DISORDER 296 0.0042
593 TASTE DISORDER 85 0.0042
594 DYSTONIA 81 0.0042
595 MUSCULAR WEAKNESS 474 0.0042
596 DRY MOUTH 338 0.0042
597 SARS-COV-2 TEST POSITIVE 55 0.0042
598 ARRHYTHMIA 197 0.0042
599 VERTIGO 253 0.0041
600 APPLICATION SITE RASH 57 0.0041
601 EYE DISCHARGE 43 0.0041
602 EATING DISORDER 88 0.0041
603 TENDON RUPTURE 51 0.0041
604 OEDEMA PERIPHERAL 503 0.0041
605 WEIGHT DECREASED 1151 0.0041
606 DEVICE OCCLUSION 58 0.0041
607 IMPAIRED HEALING 135 0.0041
608 SPEECH DISORDER 215 0.0041
609 ACUTE MYOCARDIAL INFARCTION 121 0.0041
610 SYNCOPE 410 0.0041
611 EAR DISCOMFORT 42 0.0041
612 PULMONARY EMBOLISM 388 0.0041
613 DYSPHAGIA 386 0.0041
614 COLITIS 154 0.0041
615 AGITATION 298 0.0041
616 LIP SWELLING 135 0.0040
617 MUSCULOSKELETAL PAIN 212 0.0040
618 LUNG DISORDER 198 0.0040
619 NIGHT SWEATS 130 0.0040
620 PETECHIAE 42 0.0040
621 MACULAR DEGENERATION 48 0.0040
622 HAIR COLOUR CHANGES 50 0.0040
623 VOMITING 1888 0.0040
624 PAIN IN EXTREMITY 1178 0.0040
625 FATIGUE 3110 0.0040
626 DYSPHONIA 232 0.0040
627 RHINORRHOEA 256 0.0040
628 SKIN DISORDER 132 0.0040
629 THYROID DISORDER 61 0.0040
630 DYSKINESIA 160 0.0039
631 MENTAL DISORDER 171 0.0039
632 DYSPNOEA 2221 0.0039
633 TREMOR 651 0.0039
634 GALLBLADDER DISORDER 70 0.0039
635 BLOOD PRESSURE FLUCTUATION 94 0.0039
636 SECRETION DISCHARGE 49 0.0039
637 NAUSEA 3094 0.0039
638 HEAD DISCOMFORT 69 0.0039
639 DRUG INTOLERANCE 375 0.0039
640 BLOOD POTASSIUM INCREASED 63 0.0039
641 FEELING COLD 108 0.0039
642 TEMPERATURE INTOLERANCE 40 0.0039
643 SKIN LESION 106 0.0039
644 BLISTER 217 0.0039
645 LUNG INFECTION 60 0.0039
646 PRODUCT ADMINISTRATION ERROR 78 0.0039
647 TOOTH EXTRACTION 48 0.0039
648 FACE OEDEMA 65 0.0039
649 PERICARDIAL EFFUSION 89 0.0038
650 RETCHING 82 0.0038
651 CHOLELITHIASIS 126 0.0038
652 PRODUCT AVAILABILITY ISSUE 87 0.0038
653 PRODUCT USE ISSUE 715 0.0038
654 HYPOKINESIA 55 0.0038
655 BLINDNESS 154 0.0038
656 CHOLECYSTITIS 45 0.0038
657 APPLICATION SITE ERYTHEMA 99 0.0038
658 SCAB 43 0.0038
659 CHOLECYSTECTOMY 43 0.0038
660 BALANCE DISORDER 325 0.0038
661 PULMONARY FIBROSIS 72 0.0037
662 BLOOD PRESSURE SYSTOLIC INCREASED 73 0.0037
663 ALTERED STATE OF CONSCIOUSNESS 81 0.0037
664 PARAESTHESIA 586 0.0037
665 BREAST CANCER METASTATIC 40 0.0037
666 GASTRITIS 98 0.0037
667 SWELLING FACE 242 0.0037
668 MUSCLE SPASMS 682 0.0037
669 MUSCULOSKELETAL STIFFNESS 325 0.0037
670 MUSCLE ATROPHY 47 0.0037
671 DISORIENTATION 147 0.0037
672 URTICARIA 621 0.0037
673 RED BLOOD CELL SEDIMENTATION RATE INCREASED 41 0.0037
674 DECREASED APPETITE 860 0.0037
675 DYSSTASIA 108 0.0037
676 FULL BLOOD COUNT DECREASED 74 0.0037
677 PRODUCT QUALITY ISSUE 498 0.0037
678 DEEP VEIN THROMBOSIS 238 0.0037
679 MUSCLE SPASTICITY 45 0.0037
680 SNEEZING 82 0.0037
681 BEDRIDDEN 48 0.0036
682 HEPATIC STEATOSIS 68 0.0036
683 HAEMATURIA 125 0.0036
684 INJECTION SITE EXTRAVASATION 45 0.0036
685 PRODUCT DOSE OMISSION IN ERROR 103 0.0036
686 PHOTOSENSITIVITY REACTION 60 0.0036
687 ADRENAL INSUFFICIENCY 44 0.0036
688 SKIN REACTION 51 0.0036
689 BONE DENSITY DECREASED 113 0.0036
690 HYPERSOMNIA 103 0.0036
691 GAIT INABILITY 120 0.0036
692 PULMONARY ARTERIAL HYPERTENSION 52 0.0036
693 TRANSIENT ISCHAEMIC ATTACK 121 0.0036
694 POISONING 45 0.0036
695 ABDOMINAL PAIN 833 0.0036
696 DRUG EFFECT LESS THAN EXPECTED 53 0.0036
697 C-REACTIVE PROTEIN INCREASED 130 0.0036
698 ARTHROPATHY 198 0.0036
699 SEDATION 93 0.0035
700 METASTASES TO LUNG 41 0.0035
701 MEDICATION ERROR 197 0.0035
702 DERMATITIS 74 0.0035
703 SURGERY 207 0.0035
704 DEPRESSION 801 0.0035
705 ASPARTATE AMINOTRANSFERASE INCREASED 187 0.0035
706 GINGIVAL BLEEDING 48 0.0035
707 OBESITY 56 0.0035
708 HIP FRACTURE 113 0.0035
709 ERYTHEMA 722 0.0035
710 THROAT TIGHTNESS 95 0.0035
711 PERICARDITIS 59 0.0035
712 DIABETES MELLITUS 267 0.0035
713 FEEDING DISORDER 71 0.0035
714 PERIPHERAL COLDNESS 48 0.0035
715 IMMUNE SYSTEM DISORDER 46 0.0035
716 PRODUCT PRESCRIBING ISSUE 76 0.0035
717 DIZZINESS 1734 0.0035
718 COGNITIVE DISORDER 162 0.0035
719 RECTAL HAEMORRHAGE 149 0.0035
720 CORONARY ARTERY DISEASE 105 0.0035
721 RASH MACULO-PAPULAR 77 0.0035
722 MADAROSIS 40 0.0034
723 HAIR TEXTURE ABNORMAL 46 0.0034
724 GAIT DISTURBANCE 658 0.0034
725 PANCYTOPENIA 192 0.0034
726 INTENTIONAL DOSE OMISSION 97 0.0034
727 BONE PAIN 199 0.0034
728 PREGNANCY 68 0.0034
729 HYPERHIDROSIS 434 0.0034
730 THROAT IRRITATION 151 0.0034
731 PRODUCT PREPARATION ERROR 69 0.0034
732 JOINT STIFFNESS 88 0.0034
733 METASTASES TO BONE 55 0.0033
734 SKIN CANCER 72 0.0033
735 BLOOD ALKALINE PHOSPHATASE INCREASED 83 0.0033
736 DRUG ABUSE 278 0.0033
737 AMNESIA 217 0.0033
738 METASTASES TO CENTRAL NERVOUS SYSTEM 43 0.0033
739 BLOOD BILIRUBIN INCREASED 90 0.0033
740 ASTHENIA 1252 0.0033
741 ARTHRALGIA 1383 0.0033
742 HYPERSENSITIVITY 617 0.0033
743 INCORRECT PRODUCT ADMINISTRATION DURATION 72 0.0033
744 RASH PRURITIC 179 0.0033
745 MENTAL IMPAIRMENT 80 0.0033
746 HAEMOGLOBIN DECREASED 336 0.0033
747 PNEUMONITIS 89 0.0033
748 INTESTINAL OBSTRUCTION 123 0.0033
749 GASTRIC ULCER 62 0.0033
750 RENAL DISORDER 152 0.0033
751 INTENTIONAL PRODUCT MISUSE 285 0.0033
752 ACTIVITIES OF DAILY LIVING IMPAIRED 64 0.0032
753 FLUID OVERLOAD 47 0.0032
754 PALPITATIONS 378 0.0032
755 HYPOPHAGIA 82 0.0032
756 HALLUCINATION 241 0.0032
757 RASH 1392 0.0032
758 VISION BLURRED 438 0.0032
759 POLLAKIURIA 133 0.0032
760 INFLAMMATION 164 0.0032
761 LACRIMATION INCREASED 96 0.0032
762 MALAISE 1385 0.0032
763 BLOOD CREATININE INCREASED 206 0.0032
764 TREATMENT FAILURE 261 0.0031
765 CONVULSION 180 0.0031
766 CARDIAC FAILURE CONGESTIVE 252 0.0031
767 DIARRHOEA 2014 0.0031
768 BLOOD TRIGLYCERIDES INCREASED 55 0.0031
769 OSTEONECROSIS OF JAW 77 0.0031
770 STEVENS-JOHNSON SYNDROME 69 0.0031
771 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 149 0.0031
772 TOOTH LOSS 64 0.0031
773 DRY EYE 154 0.0031
774 OFF LABEL USE 2684 0.0031
775 DEAFNESS 80 0.0031
776 CENTRAL NERVOUS SYSTEM LESION 42 0.0031
777 WEIGHT INCREASED 681 0.0030
778 DIALYSIS 43 0.0030
779 MOBILITY DECREASED 217 0.0030
780 PARANOIA 52 0.0030
781 PLATELET COUNT DECREASED 319 0.0030
782 CARDIAC DISORDER 280 0.0030
783 SENSORY DISTURBANCE 48 0.0030
784 DISTURBANCE IN ATTENTION 161 0.0030
785 PRODUCT USE COMPLAINT 47 0.0030
786 CONDITION AGGRAVATED 905 0.0030
787 HYPERTHYROIDISM 43 0.0030
788 ALANINE AMINOTRANSFERASE INCREASED 182 0.0030
789 MEMORY IMPAIRMENT 406 0.0030
790 IMMUNODEFICIENCY 44 0.0029
791 THROMBOCYTOPENIA 330 0.0029
792 GENERAL PHYSICAL HEALTH DETERIORATION 340 0.0029
793 MULTIPLE FRACTURES 48 0.0029
794 INSOMNIA 777 0.0029
795 FEELING HOT 178 0.0029
796 OVERDOSE 626 0.0029
797 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 206 0.0029
798 PSYCHOMOTOR HYPERACTIVITY 48 0.0029
799 HAEMORRHAGE 302 0.0029
800 DYSPEPSIA 284 0.0029
801 FLUSHING 293 0.0029
802 JOINT SWELLING 347 0.0029
803 HEPATIC CIRRHOSIS 54 0.0029
804 ORTHOSTATIC HYPOTENSION 50 0.0029
805 NERVOUSNESS 150 0.0029
806 MYALGIA 488 0.0029
807 SUBDURAL HAEMATOMA 41 0.0029
808 PRURITUS 1096 0.0028
809 NEUTROPHIL COUNT DECREASED 116 0.0028
810 OSTEONECROSIS 93 0.0028
811 ANGINA PECTORIS 81 0.0028
812 PLASMA CELL MYELOMA 110 0.0028
813 DRUG INEFFECTIVE 3715 0.0028
814 CARDIAC FAILURE 226 0.0028
815 RASH PAPULAR 63 0.0028
816 FEELING ABNORMAL 673 0.0028
817 HIP ARTHROPLASTY 43 0.0028
818 IMPAIRED WORK ABILITY 60 0.0028
819 RASH ERYTHEMATOUS 133 0.0028
820 RASH MACULAR 97 0.0028
821 PANIC ATTACK 101 0.0028
822 PELVIC PAIN 50 0.0027
823 HYPOCALCAEMIA 52 0.0027
824 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 64 0.0027
825 ABDOMINAL DISCOMFORT 459 0.0027
826 NEUTROPENIA 368 0.0027
827 INCORRECT ROUTE OF DRUG ADMINISTRATION 96 0.0027
828 WHITE BLOOD CELL COUNT DECREASED 291 0.0027
829 EOSINOPHILIA 47 0.0027
830 EYE DISORDER 88 0.0027
831 ABDOMINAL PAIN UPPER 550 0.0027
832 FLATULENCE 151 0.0027
833 FOETAL EXPOSURE DURING PREGNANCY 216 0.0027
834 DELUSION 41 0.0026
835 THERAPY INTERRUPTED 188 0.0026
836 PRODUCT PHYSICAL ISSUE 53 0.0026
837 SYSTEMIC LUPUS ERYTHEMATOSUS 93 0.0026
838 TRANSAMINASES INCREASED 58 0.0026
839 AGEUSIA 65 0.0026
840 HAEMATEMESIS 66 0.0026
841 HOT FLUSH 196 0.0026
842 CEREBRAL HAEMORRHAGE 93 0.0026
843 CEREBROVASCULAR ACCIDENT 438 0.0026
844 VISUAL IMPAIRMENT 320 0.0026
845 HEPATIC FAILURE 77 0.0026
846 MOVEMENT DISORDER 82 0.0026
847 RHEUMATOID ARTHRITIS 289 0.0025
848 LIVER DISORDER 112 0.0025
849 GASTROINTESTINAL HAEMORRHAGE 209 0.0025
850 OCULAR HYPERAEMIA 118 0.0025
851 ADVERSE DRUG REACTION 223 0.0025
852 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 42 0.0025
853 KNEE ARTHROPLASTY 52 0.0025
854 FEELING JITTERY 47 0.0025
855 THERAPEUTIC RESPONSE UNEXPECTED 110 0.0024
856 SUICIDAL IDEATION 224 0.0024
857 HYPERGLYCAEMIA 89 0.0024
858 SYNOVITIS 44 0.0024
859 DRUG ERUPTION 43 0.0024
860 GLOSSODYNIA 54 0.0024
861 THIRST 43 0.0024
862 DEMENTIA 67 0.0024
863 ALOPECIA 470 0.0024
864 NEOPLASM PROGRESSION 83 0.0024
865 INTENTIONAL OVERDOSE 153 0.0024
866 INTERNATIONAL NORMALISED RATIO INCREASED 68 0.0024
867 THERAPEUTIC PRODUCT EFFECT DECREASED 106 0.0024
868 CRYING 86 0.0024
869 MIDDLE INSOMNIA 44 0.0024
870 DYSGEUSIA 175 0.0024
871 SKIN FISSURES 46 0.0024
872 ISCHAEMIC STROKE 42 0.0024
873 EYE SWELLING 87 0.0023
874 EMOTIONAL DISORDER 72 0.0023
875 EPILEPSY 71 0.0023
876 INJECTION SITE SWELLING 177 0.0023
877 DISEASE PROGRESSION 273 0.0023
878 FAECES DISCOLOURED 50 0.0023
879 APPLICATION SITE PRURITUS 52 0.0023
880 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 42 0.0023
881 BLOOD GLUCOSE DECREASED 110 0.0023
882 HOSPITALISATION 351 0.0023
883 PROTEINURIA 43 0.0023
884 MUSCULOSKELETAL DISORDER 43 0.0023
885 MALIGNANT NEOPLASM PROGRESSION 231 0.0023
886 CHOKING 44 0.0023
887 THINKING ABNORMAL 42 0.0023
888 GASTRIC DISORDER 77 0.0022
889 TYPE 2 DIABETES MELLITUS 75 0.0022
890 PRESCRIBED OVERDOSE 43 0.0022
891 ABDOMINAL PAIN LOWER 56 0.0022
892 PSORIATIC ARTHROPATHY 89 0.0022
893 WITHDRAWAL SYNDROME 92 0.0022
894 INJECTION SITE MASS 81 0.0022
895 RHABDOMYOLYSIS 91 0.0022
896 PSYCHOTIC DISORDER 64 0.0022
897 HYPOGLYCAEMIA 105 0.0022
898 LACTIC ACIDOSIS 70 0.0022
899 HYPOACUSIS 93 0.0022
900 EYE IRRITATION 124 0.0022
901 BLOOD CREATINE PHOSPHOKINASE INCREASED 62 0.0022
902 SKIN EXFOLIATION 181 0.0021
903 ECZEMA 112 0.0021
904 MELAENA 47 0.0021
905 SKIN IRRITATION 97 0.0021
906 BLOOD GLUCOSE ABNORMAL 39 0.0021
907 THERAPEUTIC RESPONSE DECREASED 128 0.0021
908 HAEMATOCHEZIA 116 0.0021
909 DEPRESSED MOOD 111 0.0021
910 HEPATIC ENZYME INCREASED 141 0.0021
911 COMPLICATION OF DEVICE INSERTION 41 0.0021
912 NEOPLASM MALIGNANT 137 0.0021
913 DEVICE DISLOCATION 88 0.0020
914 THERAPEUTIC RESPONSE SHORTENED 67 0.0020
915 INJECTION SITE PRURITUS 135 0.0020
916 LABORATORY TEST ABNORMAL 59 0.0020
917 INJECTION SITE PAIN 612 0.0020
918 TREATMENT NONCOMPLIANCE 109 0.0020
919 DEATH 1711 0.0020
920 MOOD ALTERED 54 0.0020
921 EXTRAPYRAMIDAL DISORDER 49 0.0020
922 CARDIOVASCULAR DISORDER 50 0.0020
923 PANCREATITIS 104 0.0020
924 NIGHTMARE 68 0.0020
925 INJECTION SITE ERYTHEMA 239 0.0019
926 ILL-DEFINED DISORDER 117 0.0019
927 FREQUENT BOWEL MOVEMENTS 52 0.0019
928 CEREBRAL INFARCTION 47 0.0019
929 LEUKOPENIA 95 0.0019
930 AGGRESSION 95 0.0019
931 IRRITABILITY 114 0.0019
932 EXPIRED PRODUCT ADMINISTERED 63 0.0019
933 RASH GENERALISED 49 0.0019
934 PRODUCT DOSE OMISSION 120 0.0018
935 INJECTION SITE BRUISING 144 0.0018
936 DRY SKIN 240 0.0018
937 DRUG ADMINISTRATION ERROR 55 0.0018
938 HEPATIC FUNCTION ABNORMAL 66 0.0018
939 DRUG EFFECT INCOMPLETE 64 0.0018
940 WRONG TECHNIQUE IN DRUG USAGE PROCESS 64 0.0018
941 LIVER INJURY 43 0.0018
942 CONTRAINDICATED PRODUCT ADMINISTERED 53 0.0017
943 INJECTION SITE REACTION 120 0.0017
944 MYOCARDIAL INFARCTION 303 0.0017
945 EYE PRURITUS 58 0.0017
946 MULTIPLE SCLEROSIS 82 0.0017
947 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 50 0.0017
948 NO ADVERSE EVENT 307 0.0017
949 DRUG EFFECT DECREASED 91 0.0017
950 INCORRECT DOSE ADMINISTERED 382 0.0017
951 DEVICE ISSUE 150 0.0017
952 VAGINAL HAEMORRHAGE 72 0.0017
953 FEMUR FRACTURE 51 0.0016
954 HEPATITIS 42 0.0016
955 PAIN OF SKIN 43 0.0016
956 COMPLETED SUICIDE 131 0.0016
957 ADVERSE EVENT 143 0.0016
958 ACCIDENTAL EXPOSURE TO PRODUCT 159 0.0015
959 ABNORMAL BEHAVIOUR 60 0.0015
960 INTERSTITIAL LUNG DISEASE 73 0.0015
961 DEVICE LEAKAGE 64 0.0015
962 BLOOD GLUCOSE INCREASED 277 0.0015
963 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 295 0.0015
964 SUICIDE ATTEMPT 88 0.0014
965 ABNORMAL DREAMS 40 0.0014
966 LIVER FUNCTION TEST ABNORMAL 42 0.0014
967 DRUG-INDUCED LIVER INJURY 45 0.0014
968 PRODUCT SUBSTITUTION ISSUE 80 0.0014
969 MULTIPLE SCLEROSIS RELAPSE 92 0.0013
970 DRUG EXPOSURE DURING PREGNANCY 45 0.0013
971 DRUG WITHDRAWAL SYNDROME 112 0.0013
972 THERAPY CESSATION 63 0.0012
973 DISEASE RECURRENCE 58 0.0012
974 DEVICE BREAKAGE 49 0.0012
975 INJECTION SITE HAEMORRHAGE 95 0.0012
976 EXTRA DOSE ADMINISTERED 48 0.0012
977 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 40 0.0012
978 ANGER 40 0.0012
979 PSORIASIS 152 0.0012
980 COLITIS ULCERATIVE 50 0.0011
981 DEVICE MALFUNCTION 78 0.0011
982 LUNG NEOPLASM MALIGNANT 45 0.0011
983 DERMATITIS ATOPIC 57 0.0011
984 DRUG DEPENDENCE 170 0.0011
985 SKIN BURNING SENSATION 70 0.0010
986 ACNE 72 0.0009
987 DRUG DOSE OMISSION 154 0.0009
988 BREAST CANCER 84 0.0009
989 UNDERDOSE 63 0.0009
990 DEVICE DIFFICULT TO USE 56 0.0008
991 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 52 0.0007
992 PRODUCT STORAGE ERROR 61 0.0007